Haemonetics (HAE) Return on Capital Employed Growth (3y) (2013 - 2026)
Haemonetics (HAE) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -846.00 |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -247.00 |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 1,318.00 |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | - |
| 10 | Haemonetics | 3.79 Bn | 3.55 Bn | 198.21 Mn | -218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -218.00 |
| Dec 27, 2025 | 452.00 |
| Sep 27, 2025 | 438.00 |
| Jun 28, 2025 | 562.00 |
| Mar 29, 2025 | 584.00 |
| Dec 28, 2024 | 517.00 |
| Sep 28, 2024 | 442.00 |
| Jun 29, 2024 | 213.00 |
| Mar 30, 2024 | 187.00 |
| Dec 30, 2023 | -244.00 |
| Sep 30, 2023 | -292.00 |
| Jul 1, 2023 | -317.00 |
| Apr 1, 2023 | -114.00 |
| Dec 31, 2022 | -206.00 |
| Oct 1, 2022 | -62.00 |
| Jul 2, 2022 | -4.00 |
| Apr 2, 2022 | -247.00 |
| Jan 1, 2022 | -438.00 |
| Oct 2, 2021 | -139.00 |
| Jul 3, 2021 | 74.00 |